Atlas Trials

Safety and Immunogenicity of the Placental Malaria Vaccine Candidate PAMVAC Variously Adjuvanted

Clinical trial NCT02647489 · COMPLETED

Trial details

NCT number
NCT02647489
Sponsor
University Hospital Tuebingen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Malaria, Antepartum
Start date
2016-05-01
Primary completion
2017-11-10
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.